Patient Access & Regulatory Affairs
Patient access to health products is the result of a continuous interaction among science, regulatory processes and market dynamics. The final aim is to give the patient rapid access to curative treatments, ensuring a balance between appropriateness and sustainability.
This means a change of mindset:
from Market Access to Patient Access
We accompany our Clients along the entire product’s life cycle: